Editorial & Sponsorship Policy
Ismar Healthcare is committed to providing credible, objective and reliable health content.
The Ismar Healthcare library of articles and videos is created by the Ismar Healthcare editorial staff in collaboration with the editorial board. All content receives a comprehensive review by Ismar Healthcare's medical team and editorial board.
When an Ismar Healthcare program or article is funded by a third party, it will be clearly labelled as content funded through an "Unrestricted Educational Grant" or "Educational Grant," or as a "Special Feature." Ismar Healthcare and its editorial board maintain full editorial control over all content created through third-party funding. This website is currently sponsored by an Unconditional Educational Grant of Gen-Probe Incorporated.
Editorial board
Co-Editors-in-Chief
- Prof. Jack Schalken, Nijmegen, the Netherlands
- Prof. Bertrand Tombal, Brussels, Belgium
- Prof. Hendrik Van Poppel, Leuven, Belgium
Consulting editors
- Dr. Richard Berges, Cologne, Germany
- Dr. Jacques Irani, Poitiers, France
- Dr. Paul Kil, Tilburg, the Netherlands
- Mr. James Gelister, London, UK
- Dr. Theo de Reijke, Amsterdam, the Netherlands
- Mr. Mark Speakman, Taunton, UK
Publishing staff
- Antoinnet den Buitelaar
- Bianca Meesen
- Annelies Michiels
- Louis Smets
Webmaster
- Rik Rijnders
Editorial offices
Ismar Healthcare
Duwijckstraat, 17
B-2500 Lier
Belgium
Find the answer to all your questions about PCA3 in the frequently asked questions section
Use tools from research institutions developed to predict the risk of prostate cancer